HIGH

High-Risk Antibiotic Recall: Sulfamethoxazole and Trimethoprim 800/160 mg Double Strength Packets Re

A high-risk recall of sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets is active nationwide in the United States. The Harvard Drug Group and distribution partners have halted use of a lot due to a foreign-substance finding in packaging material. No tablets tested positive for micro-organisms. Consumers should stop using the product and consult their healthcare providers.

Quick Facts at a Glance

Recall Date
September 2, 2025
Hazard Level
HIGH
Brands
SULFAMETHOXAZOLE AND TRIMETHOPRIM, Cardinal Health, Major Pharmaceuticals
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT

Hazard Information

Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

This antibiotic combines sulfamethoxazole and trimethoprim for bacterial infections. It is used under medical supervision and is distributed nationwide.

Why This Is Dangerous

A foreign-substance material in packaging raises contamination concerns. No tablets were contaminated.

Industry Context

This recall is not part of a broader industry recall pattern.

Real-World Impact

Immediate stop-use is required; potential supply disruption for patients needing antibiotics.

Practical Guidance

How to identify if yours is affected

  1. Check outer bag NDC 55154-7895-0
  2. Check inner blister NDC 0904-2725-61
  3. Look for lot N02309 on tablets or packaging
  4. Bag IDs N02309A/N02309B
  5. Verify packaging material vs tablets

Where to find product info

FDA enforcement recall page D-0625-2025 and FDA enforcement report with recall number D-0625-2025

What timeline to expect

Remedy delivery via recall notification letters; refunds/replacements governed by distributor policies

If the manufacturer is unresponsive

  • Document communications
  • Escalate to FDA recall contact
  • Consider consumer protection agencies if needed

How to prevent similar issues

  • Use authentic suppliers
  • Verify lot numbers before distribution
  • Maintain packaging integrity checks on received medicines

Documentation advice

Keep recall notice, take photos of packaging and lot numbers, note dates of receipt

Product Details

Product: Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg double strength, 10 tablets per blister pack (10x1) per bag. Distributors: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories. Distributed by Cardinal Health, Dublin, OH 43017. NDC: 55154-7895-0. Outer bag contains NDC 0904-2725-61 in inner blisters. Lot: N02309. Bag identifiers: Bag N02309A and N02309B.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Nationwide distribution in the USA
  • Active recall dated 2025-09-02
  • High hazard level
  • Lot N02309 with bag identifiers N02309A/N02309B
  • Inner blister lot N02309
  • NDC 55154-7895-0 outer bag; inner NDC 0904-2725-61

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANT
Injury Types
POISONINGELECTRICAL

Product Classification

Product Details

Model Numbers
Bag: N02309A
Bag: N02309B
Inner blister: Lot N02309
UPC Codes
55154-7895
0904-2725
55154-7895-0
+1 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more